[Recent trends in therapy in patients with idiopathic thrombocytopenic purpura].
Nomura
T
T
D001205:Ascorbic Acid / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D016898:Interferon-alpha / Q000627:therapeutic use; D017713:Platelet Transfusion; D011239:Prednisolone / Q000008:administration & dosage*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*; D013156:Splenectomy; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D014750:Vincristine; D014747:Vinblastine; D011239:Prednisolone; D001205:Ascorbic Acid